Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Pharmaceutical Business Review
Return to: PBR Home
Search Refinements

News

View news from other Pharmaceutical sectors:
136-150 of 45562 results
Invetech, Argos ink deal to support global production of fully personalized immunotherapies
Invetech, a global leader in instrument development, custom automation and contract manufacturing, and Argos Therapeutics, a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases, have entered into an agreement under which Invetech will develop and supply manufacturing systems to support production needs for fully personalized immunotherapies based on Argos' Arcelis technology platform.
News
The Medicines Company enrolls first patient in Phase III studies of CARBAVANCE to treat serious bacterial infections
The Medicines Company announced enrollment of the first patient in its Phase 3 clinical trial program for CARBAVANCE (meropenem/RPX7009), an investigational intravenous antibiotic under development for the treatment of serious bacterial infections due to gram-negative bacteria, particularly KPC (Klebsiella pneumoniae carbapenemase)-producing carbapenem-resistant Enterobacteriaceae (CRE).
News
BioLineRx reports final results of Phase I/II trial for new celiac treatment
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, has announced successful final results from its Phase I/II study for BL-7010, a novel co-polymer for the treatment of celiac disease.
News
GSK seeks approval for asthma drug mepolizumab in US and Europe
By PBR Staff Writer
GlaxoSmithKline (GSK) has filed regulatory submissions in the US and Europe seeking approval for mepolizumab, a monoclonal antibody, as a maintenance treatment for patients with severe eosinophilic asthma.
News
Advaxis files IND application to FDA for prostate cancer drug ADXS31-142
By PBR Staff Writer
US-based biotechnology firm Advaxis has submitted an investigational new drug (IND) application to the US Food and Drug Administration (FDA) to conduct the first-in-human trial of ADXS31-142 to treat metastatic castration resistant prostate cancer (mCRPC).
News
Eli Lilly gets FDA approval for gastric cancer combination drug
By PBR Staff Writer
Eli Lilly and Company has received the US Food and Drug Administration (FDA) approval for Cyramza (ramucirumab) in combination with paclitaxel (a type of chemotherapy) to treat advanced or metastatic gastric (stomach) or gastroesophageal junction (GEJ) adenocarcinoma.
News
UK opens new Ebola treatment centre in Sierra Leone
By PBR Staff Writer
A new British funded and staffed health centre to treat people with the deadly virus Ebola has opened in Kerry Town, near the Sierra Leone capital Freetown.
News
Ranbaxy gets FDA approval to market fenofibrate capsules USP, 43mg and 130mg
Ranbaxy Laboratories has received approval from the U.S. Food and Drug Administration to manufacture and market Fenofibrate Capsules USP, 43 mg and 130 mg.
News
Genzyme enrolls first patient in Phase II vatelizumab trial in RRMS patients
By PBR Staff Writer
Sanofi's Genzyme has started enrolling patients in a multicenter Phase II clinical trial (EMPIRE) of its investigational infusion therapy vatelizumab in patients with relapsing remitting multiple sclerosis (RRMS).
News
Ruthigen starts patient enrolment in Phase I/II trial of RUT58-60
By PBR Staff Writer
US-based biopharmaceutical firm Ruthigen has started patient enrollment in a Phase I/II clinical trial of its lead drug candidate, RUT58-60, designed for prophylactic use during invasive surgical procedures.
News
EMA panel grants positive opinion on ODD of Inventiva's IVA337
By PBR Staff Writer
The European Medicines Agency's (EMA) Committee for Orphan Medicinal Products (COMP) has given a positive opinion on the designation of French drug discovery firm Inventiva's lead clinical candidate IVA337 as an orphan medicinal product to treat Systemic Sclerosis (SSc).
News
Imprimis signs distribution deal to bring Go Dropless proprietary formulations to ophthalmologists in Puerto Rico
Imprimis Pharmaceuticals, a specialty pharmaceutical company focused on the development and commercialization of proprietary sterile and topical compounded drug formulations, has entered into a distribution agreement with MD Distributor.
News
Baxter to build new intravenous admixing facility in Mississauga, Canada
Baxter Corporation is investing $10m to build a new facility in Mississauga, Ontario for its Centralized Intravenous Admixing Pharmacy Service (CIVA).
News
Dana-Farber Cancer Institute, Astellas to research and develop small molecule inhibitors of oncogenic K-Ras
Dana-Farber Cancer Institute and Astellas Pharma has announced a three-year collaboration to research and develop small molecule inhibitors of oncogenic K-Ras for the treatment of cancer, including lung cancer.
News
D-Pharm reports first results from its phase 2 clinical study of THR-18
D-Pharm reported top-line safety results following completion of its Phase 2 clinical study of THR-18 in acute ischemic stroke (AIS) patients treated with tissue plasminogen activator (tPA).
News
136-150 of 45562 results